Eterna Therapeutics announced the appointment of Peter Cicala, JD, to its Board of Directors. Cicala’s most recent experience involves advising start-up and venture-backed biotechnology companies through all aspects of drug development and the protection of proprietary technologies, including long-range strategic planning and commercialization of therapeutics.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ERNA:
- Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors
- Eterna Therapeutics Welcomes New Board Member Peter Cicala
- Eterna files to sell 18.23M shares of common stock for holders
- Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
- EternaAppoints Sanjeev Luther as President and CEO